Moving Towards an Integrated Approach to Allergic Rhinitis Management: ARIA and EUFOREA Guidelines Similarities and Differences.

IF 4.6 2区医学 Q1 ALLERGY

Current Allergy and Asthma Reports Pub Date : 2025-07-24 DOI:10.1007/s11882-025-01212-x

Désirée E S Larenas-Linnemann, Lawrence Chun-Wei Loy, Baharudin Abdullah, Glenis Kathleen Scadding

{"title":"Moving Towards an Integrated Approach to Allergic Rhinitis Management: ARIA and EUFOREA Guidelines Similarities and Differences.","authors":"Désirée E S Larenas-Linnemann, Lawrence Chun-Wei Loy, Baharudin Abdullah, Glenis Kathleen Scadding","doi":"10.1007/s11882-025-01212-x","DOIUrl":null,"url":null,"abstract":"Purpose of review: This review aims to raise awareness of the Allergic Rhinitis and its Impact on Asthma (ARIA) and European Forum for Research and Education in Allergy and Airway Disease (EUFOREA) guidelines for allergic rhinitis (AR) by presenting a side-by-side summary of their key elements. Drawing on the authors' direct involvement in the development of both, it highlights their evolution toward precision medicine and patient-centred care to support stronger doctor-patient partnerships.Recent findings: Both ARIA and EUFOREA offer evidence-based guidance to support AR management, with increasing emphasis on personalisation and digital integration. While aligned in goals, they differ in patient classification, treatment delivery, and implementation strategies. Barriers to real-world use include the need for contextual adaptation, targeted education for healthcare providers and patients, and inconsistent alignment between guideline-based prescriptions and patient behaviour. Mobile health (mHealth) tools offer valuable support but require sustained engagement. Greater awareness of these guidelines can improve implementation, harmonise treatment approaches, and ultimately enhance care delivery and outcomes for individuals with AR.","PeriodicalId":55198,"journal":{"name":"Current Allergy and Asthma Reports","volume":"25 1","pages":"30"},"PeriodicalIF":4.6000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Allergy and Asthma Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11882-025-01212-x","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: This review aims to raise awareness of the Allergic Rhinitis and its Impact on Asthma (ARIA) and European Forum for Research and Education in Allergy and Airway Disease (EUFOREA) guidelines for allergic rhinitis (AR) by presenting a side-by-side summary of their key elements. Drawing on the authors' direct involvement in the development of both, it highlights their evolution toward precision medicine and patient-centred care to support stronger doctor-patient partnerships.

Recent findings: Both ARIA and EUFOREA offer evidence-based guidance to support AR management, with increasing emphasis on personalisation and digital integration. While aligned in goals, they differ in patient classification, treatment delivery, and implementation strategies. Barriers to real-world use include the need for contextual adaptation, targeted education for healthcare providers and patients, and inconsistent alignment between guideline-based prescriptions and patient behaviour. Mobile health (mHealth) tools offer valuable support but require sustained engagement. Greater awareness of these guidelines can improve implementation, harmonise treatment approaches, and ultimately enhance care delivery and outcomes for individuals with AR.

查看原文本刊更多论文

走向变应性鼻炎管理的综合方法：ARIA和EUFOREA指南的异同。

综述目的：本综述旨在通过对过敏性鼻炎（AR）的关键要素进行并列总结，提高人们对过敏性鼻炎及其对哮喘的影响（ARIA）和欧洲过敏和气道疾病研究与教育论坛（EUFOREA）过敏性鼻炎（AR）指南的认识。利用作者直接参与两者的发展，它强调了它们向精确医学和以患者为中心的护理的演变，以支持更强大的医患伙伴关系。最近的发现：ARIA和EUFOREA都提供了基于证据的指导，以支持AR管理，并越来越强调个性化和数字集成。虽然目标一致，但在患者分类、治疗交付和实施策略方面存在差异。在现实世界中使用的障碍包括需要适应环境，对医疗保健提供者和患者进行有针对性的教育，以及基于指南的处方与患者行为之间不一致。移动医疗（mHealth）工具提供了宝贵的支持，但需要持续参与。提高对这些指南的认识可以改善实施，协调治疗方法，并最终改善AR患者的护理提供和结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Allergy and Asthma Reports 医学-过敏

CiteScore

11.20

自引率

1.80%

发文量

审稿时长

6-12 weeks

期刊介绍： The aim of Current Allergy and Asthma Reports is to systematically provide the views of highly selected experts on current advances in the fields of allergy and asthma and highlight the most important papers recently published. All reviews are intended to facilitate the understanding of new advances in science for better diagnosis, treatment, and prevention of allergy and asthma. We accomplish this aim by appointing international experts in major subject areas across the discipline to review select topics emphasizing recent developments and highlighting important new papers and emerging concepts. We also provide commentaries from well-known figures in the field, and an Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research. Over a one- to two-year period, readers are updated on all the major advances in allergy and asthma.